REFERENCES
- American Thoracic Society. Dyspnea: mechanism, assessment, and management. A consensus statement. Am J Respir Crit Care Med. 1999;159:321–340.
- Thomas S, Bausewein C, Higginson I, Booth S. Breathlessness in cancer patients—implications, management and challenges. Eur J Oncol Nurs. 2011;15:459–469.
- Cachia E, Hjelmeland A. Breathlessness in cancer patients. Eur J Cancer. 2008;44:1116–1123.
- Dudgeon D, Kristjanson L, Solan J, Lertzman M, Clement K. Dyspnea in cancer patients: prevalence and associated factor. J Pain Symptom Manage. 2001;21:95–102.
- Bailey P, Lu J, Pace N, et al. Effects of intratecal morphine on the ventilatory response to hypoxia. N Engl J Med. 2000;343:1228–1234.
- Mahler D, Murray J, Waterman L, et al. Endogenous opioids modify dyspnea during treadmill exercise in patients with COPD. Eur Respir J. 2009;33:771–777.
- Jennings L, Davies J, Higgins, et al. A systematic review of the use of opioides in the management of dyspnea. Thorax. 2002;57:939–944.
- Ben-Aharon I, Gafter-Gvili A, Leibovici L, Stemmer S. Interventions for alleviating cancer related dyspnea: a systematic review. J Clin Oncol. 2008;26:2396–2404.
- Ben-Aharon I, Gafter-Gvili A, Leibovici L, Stemmer S. Interventions for alleviating cancer related dyspnea: a systematic review and meta-analysis. Acta Oncol. 2012;51:996–1008.
- Simon S, Higgindon I, Benalia H, et al. Episodic and continuous breathlessness: a new categorization of breathlessness. J Pain Symptom Manage. 2013;45:1019–1029.
- Simon S, Weingartner V, Higginson I, Voltz R, Bausewein C. Definition, categorization, and terminology of episodic breathlessness: consensus by an International Delphi Survey. J Pain Symptom Manage. 2014;47:828–838.
- Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0. March 2011. Available at: http://www.cochrane.org/training/cochrane-handbook. Accessed November 10th, 2014.
- Urrútia G, Bonfill X. PRISMA Declaration: a proposal to improve the publication of systematic reviews and meta-analyses. Med Clin. 2010;135:507–511.
- Mazzocato C, Buclin T, Rapin C. The effects of morphine on dyspnea and ventilatory function in elderly patients with advanced cancer: a randomized double-blind controlled trial. Ann Oncol. 1999;10:1511–1514.
- Allard P, Lamontagne C, Bernard P, Tremblay C. How effective are supplementary doses of opioids for dyspnea in terminallyill cancer patients? A randomized continuous sequential clinical trial. J Pain Symptom Manage. 1999;17:256–265.
- Bruera E, Sala R, Spruyt O, Plamer L, Zhang T, Willey J. Nebulized versus subcutaneous morphine for patients with cancer dyspnea: a preliminary study. J Pain Symptom Manage. 2005;29:613–618.
- Charles M, Reymond L, Israel F. Relief of incident dyspnea in palliative cancer patients: a pilot, randomized, controlled trial comparing nebulized hydromorphone, systemic hydromorphone and nebulized saline. J Pain Symptom Manage. 2008;36:29–38.
- Navigante A, Cerchietti L, Castro M, Lutteral M, Cabalar M. Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer. J Pain Symptom Manage. 2006;31:38–47.
- Navigante A, Castro M, Cerchietti L. Morphine versus midazolam as upfront therapy to control dyspnea perception in cáncer patients while its underlying cause is sought or treated. J Pain Symptom Manage. 2010;39:820–830.
- Cuervo M, Bruera E, Redondo M, Sánchez M, Mota R. A randomized crossover clinical trial to evaluate the efficacy of oral transmucosal fentanyl citrate in the treatment of dyspnea on exertion in patients with advanced cancer. Am J Hosp Palliat Care. 2013;20:1–7.
- Hui D, Xu A, Frisbee-Hume S, et al. Effects of prophylactic subcutaneous fentanyl on exercise induced breakthrough dyspnea in cancer patients: a preliminary double blind, randomized, controlled trial. J Pain Symptom Manage. 2014;47:209–217.
- Tanaka K, Shima Y, Kakinuma R, et al. Effect of nebulized morphine in cancer patients with dyspnea: a pilot study. Jpn J Clin Oncol. 1999;29:600–603.
- Coyne P, Viswanathan R, Smith T. Nebulized fentanyl citrate improves patients´ perception of breathing, respiratory rate and oxygen saturation in dyspnea. J Pain Symptom Manage. 2002;23:157–160.
- Clemens K, Klaschik E. Effect of hydromorphone on ventilation in palliative care patients with dyspnea. Support Care Cancer. 2008;16:93–99.
- Clemens K, Quednau I, Klaschik E. Is there a higher risk of respiratory depression in opioide naïve palliative care patients during symptomatic therapy with strong opioids? J Palliat Med. 2008;11:2004–2016.
- Clemens K, Klaschik E. Symptomatic therapy of dyspnea with strong opioids and its effect on ventilation in palliative care patients. J Pain Symptom Manage. 2007;33:473–481.
- Clemens K, Quednau I, Klaschik E. Use of oxygen and opioids in the palliation of dyspnoea in hypoxic and non hypoxic palliative care patients: a prospective study. Support Care Cancer. 2009;17:367–377.